BLTE - Belite Bio ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BLTE is currently covered by 3 analysts with an average price target of $199.83. This is a potential upside of $26.52 (15.3%) from yesterday's end of day stock price of $173.31.

Belite Bio ADR's activity chart (see below) currently has 32 price targets and 39 ratings on display. The stock rating distribution of BLTE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 97.62% with an average time for these price targets to be met of 266.75 days.

Highest price target for BLTE is $185, Lowest price target is $132, average price target is $157.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 28-Jan-2026. First documented stock forecast 01-Jul-2022.

Best performing analysts who are covering BLTE - Belite Bio ADR:

Jennifer Kim Yi Chen Bruce Jackson Jason Mccarthy

Currently out of the existing stock ratings of BLTE, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Aug-2022

$185

$16 (9.47%)

$185

5 days ago
(28-Jan-2026)

19/21 (90.48%)

$19.36 (11.69%)

310

Buy Since 28-Jul-2023

$154

$-15 (-8.88%)

2 months 9 days ago
(24-Nov-2025)

2/2 (100%)

$33.44 (27.74%)

80

Buy Since 01-Jul-2022

$132

$-37 (-21.89%)

$80

3 months 2 days ago
(31-Oct-2025)

10/10 (100%)

$26.09 (24.63%)

343

Buy Since 14-Dec-2023

$110

$-59 (-34.91%)

$60

1 years 2 months 18 days ago
(15-Nov-2024)

2/2 (100%)

$27.19 (32.83%)

334

Show more analysts

Please expand the browser size to see the chart

What is BLTE (Belite Bio ADR) average time for price targets to be met?

On average it took 266.75 days on average for the stock forecasts to be realized with a an average price target met ratio 97.62

Which analyst has the current highest performing score on BLTE (Belite Bio ADR) with a proven track record?

JENNIFER KIM

Which analyst has the current lower performing score on BLTE (Belite Bio ADR) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on BLTE (Belite Bio ADR)?

Jennifer Kim works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on BLTE

Which analyst is the currently most bullish on BLTE (Belite Bio ADR)?

Yi Chen with highest potential upside - $16

Which analyst is the currently most reserved on BLTE (Belite Bio ADR)?

Jason Mccarthy with lowest potential downside - -$59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?